| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |